>
pdufa.bio

Selinexor

Updated ยทnext FDA decision on the calendar

Selinexor is a Karyopharm Therapeutics Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

KPTI catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Karyopharm Therapeutics Inc. (KPTI). We track 4 catalyst events for this program: 2 upcoming and 2 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Aug 2026KPTIReadout · Sep 2026KPTIReadout · Dec 2026KPTIReadout · Apr 2027KPTI

Questions

When is Selinexor's next FDA decision or readout?

The next tracked catalyst for Selinexor is a Readout in Dec 2026.

What happened at Selinexor's most recent FDA decision?

No FDA decision for Selinexor is in our archive yet.

Who makes Selinexor?

Karyopharm Therapeutics Inc. (KPTI).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.